Renal care companies develop business through vertical integration and innovative home care products
This article was originally published in Clinica
Although dialysis technology has changed little over the years, companies are constantly developing new treatment techniques and solutions as the number of people suffering from end-stage renal disease (ESRD) continues to climb by an annual average of 8%. Some 800,000 people worldwide require dialysis treatment making a product market of about $6 billion with the cost of treatments worth approximately $23 billion, according to a new report published by Theta Reports, entitled Kidney dialysis equipment & supplies.
You may also be interested in...
The FDA’s OPQ touts approval of sixth and seventh continuously manufactured drugs and quicker delivery of inspection results in latest annual report.
No device-related warning letters were released by the US FDA the week of 19 February.
Complex generics and value added medicines share common challenges on harmonization of regulation, lack of incentives and clarity of guidelines, heard delegates to Medicines for Europe’s Regulatory & Scientific Affairs conference.